Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Keystone Symposium on Antibodies as Drugs</title><author><name sortKey="Wurch, Thierry" sort="Wurch, Thierry" uniqKey="Wurch T" first="Thierry" last="Wurch">Thierry Wurch</name><affiliation><nlm:aff id="A1">Centre d'Immunologie Pierre FABRE; Saint Julien en Genevois, France</nlm:aff></affiliation></author><author><name sortKey="Larbouret, Christel" sort="Larbouret, Christel" uniqKey="Larbouret C" first="Christel" last="Larbouret">Christel Larbouret</name><affiliation><nlm:aff id="A2">Institut de Recherche en Cancérologie de Montpellier; INSERM U896; Université Montpellier1; CRLC Val d'Aurelle, Montpellier</nlm:aff></affiliation></author><author><name sortKey="Robert, Bruno" sort="Robert, Bruno" uniqKey="Robert B" first="Bruno" last="Robert">Bruno Robert</name><affiliation><nlm:aff id="A2">Institut de Recherche en Cancérologie de Montpellier; INSERM U896; Université Montpellier1; CRLC Val d'Aurelle, Montpellier</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">20068403</idno><idno type="pmc">2726610</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2726610</idno><idno type="RBID">PMC:2726610</idno><date when="2009">2009</date><idno type="wicri:Area/Pmc/Corpus">000349</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000349</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Keystone Symposium on Antibodies as Drugs</title><author><name sortKey="Wurch, Thierry" sort="Wurch, Thierry" uniqKey="Wurch T" first="Thierry" last="Wurch">Thierry Wurch</name><affiliation><nlm:aff id="A1">Centre d'Immunologie Pierre FABRE; Saint Julien en Genevois, France</nlm:aff></affiliation></author><author><name sortKey="Larbouret, Christel" sort="Larbouret, Christel" uniqKey="Larbouret C" first="Christel" last="Larbouret">Christel Larbouret</name><affiliation><nlm:aff id="A2">Institut de Recherche en Cancérologie de Montpellier; INSERM U896; Université Montpellier1; CRLC Val d'Aurelle, Montpellier</nlm:aff></affiliation></author><author><name sortKey="Robert, Bruno" sort="Robert, Bruno" uniqKey="Robert B" first="Bruno" last="Robert">Bruno Robert</name><affiliation><nlm:aff id="A2">Institut de Recherche en Cancérologie de Montpellier; INSERM U896; Université Montpellier1; CRLC Val d'Aurelle, Montpellier</nlm:aff></affiliation></author></analytic><series><title level="j">mAbs</title><idno type="ISSN">1942-0862</idno><idno type="eISSN">1942-0870</idno><imprint><date when="2009">2009</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>The symposium on Antibodies as Drugs, organized by Keystone Symposia and chaired by J. Marks, (University of California Los Angeles, USA), E.S. Ward (University of Texas Southwestern Medical Center, USA) and L. Weiner (Georgetown University Medical Center, USA), was held in Whistler, British Columbia. This Canadian Rockies village, which will host the 2010 Olympic Games, served as an enchanting backdrop to the meeting. The more than 350 speakers and attendees included scientists from major pharmaceutical firms, e.g., Abbott, MedImmune/Astra Zeneca, Bristol-Myers Squibb, Merck & Co., Pfizer, Sanofi-Aventis, Schering, GlaxoSmithKline, Eli Lilly, Hoffmann LaRoche, Novartis, Wyeth, and biotechnology companies, e.g., Ablynx, Medarex, Morphosys, GenMab, Amgen, Genentech, ImmunoGen, Agensys, Domantis, Biogen Idec, Centocor, LFB, Micromet, PDL Biopharma, Borean Pharma, Dyax Corp., Symphogen and Syntonix. Academic research groups at Imperial College London, University of Oxford, ETH Zürich, Scripps, Institute Cochin, Karolinska Institute, Utrecht University, Harvard Medical School, Massachusetts Institute of Technology, Baylor College, Paul Ehrlich Institute, University of California San Francisco, University of California San Diego, University of Nantes, University of Tours and Ludwig Institute were also represented, as were regulatory authorities, including the US Food and Drug Administration, National Institutes of Health and the Public Health Agency of Canada). The meeting was very interactive and included thoughtful exchanges during the different sessions and networking events.</p></div></front></TEI><pmc article-type="meeting-report"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">MAbs</journal-id><journal-id journal-id-type="publisher-id">mAbs</journal-id><journal-title-group><journal-title>mAbs</journal-title></journal-title-group><issn pub-type="ppub">1942-0862</issn><issn pub-type="epub">1942-0870</issn><publisher><publisher-name>Landes Bioscience</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">20068403</article-id><article-id pub-id-type="pmc">2726610</article-id><article-id pub-id-type="publisher-id">1942-0862-1-4-3</article-id><article-categories><subj-group subj-group-type="heading"><subject>Meeting Report</subject></subj-group></article-categories><title-group><article-title>Keystone Symposium on Antibodies as Drugs</article-title><subtitle>March 27–April 1, 2009, Whistler, BC CA</subtitle></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Wurch</surname><given-names>Thierry</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Larbouret</surname><given-names>Christel</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Robert</surname><given-names>Bruno</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib></contrib-group><aff id="A1"><label>1</label>Centre d'Immunologie Pierre FABRE; Saint Julien en Genevois, France</aff><aff id="A2"><label>2</label>Institut de Recherche en Cancérologie de Montpellier; INSERM U896; Université Montpellier1; CRLC Val d'Aurelle, Montpellier</aff><author-notes><corresp>Correspondence to: Thierry Wurch; Head, Cellular and Molecular Biology Department; Institut de Recherche Pierre Fabre; 5, Avenue Napoléon III; BP 497; St Julien-en-Genevois 74164 France; Tel.: +33.4.50.35.35.78; Email: <email>thierry.wurch@pierre-fabre.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jul-Aug</season><year>2009</year></pub-date><volume>1</volume><issue>4</issue><fpage>318</fpage><lpage>325</lpage><history><date date-type="received"><day>28</day><month>5</month><year>2009</year></date><date date-type="accepted"><day>28</day><month>5</month><year>2009</year></date></history><permissions><copyright-statement>Copyright © 2009 Landes Bioscience</copyright-statement><copyright-year>2009</copyright-year></permissions><abstract><p>The symposium on Antibodies as Drugs, organized by Keystone Symposia and chaired by J. Marks, (University of California Los Angeles, USA), E.S. Ward (University of Texas Southwestern Medical Center, USA) and L. Weiner (Georgetown University Medical Center, USA), was held in Whistler, British Columbia. This Canadian Rockies village, which will host the 2010 Olympic Games, served as an enchanting backdrop to the meeting. The more than 350 speakers and attendees included scientists from major pharmaceutical firms, e.g., Abbott, MedImmune/Astra Zeneca, Bristol-Myers Squibb, Merck & Co., Pfizer, Sanofi-Aventis, Schering, GlaxoSmithKline, Eli Lilly, Hoffmann LaRoche, Novartis, Wyeth, and biotechnology companies, e.g., Ablynx, Medarex, Morphosys, GenMab, Amgen, Genentech, ImmunoGen, Agensys, Domantis, Biogen Idec, Centocor, LFB, Micromet, PDL Biopharma, Borean Pharma, Dyax Corp., Symphogen and Syntonix. Academic research groups at Imperial College London, University of Oxford, ETH Zürich, Scripps, Institute Cochin, Karolinska Institute, Utrecht University, Harvard Medical School, Massachusetts Institute of Technology, Baylor College, Paul Ehrlich Institute, University of California San Francisco, University of California San Diego, University of Nantes, University of Tours and Ludwig Institute were also represented, as were regulatory authorities, including the US Food and Drug Administration, National Institutes of Health and the Public Health Agency of Canada). The meeting was very interactive and included thoughtful exchanges during the different sessions and networking events.</p></abstract></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 0003499 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 0003499 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé=
|texte=
}}
| This area was generated with Dilib version V0.6.29. |  |